Theravance Biopharma, Inc.
TBPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56 | -$55 | -$93 | -$265 |
| Dep. & Amort. | $4 | $4 | $7 | $9 |
| Deferred Tax | -$8 | $3 | $0 | $0 |
| Stock-Based Comp. | $21 | $25 | $40 | $62 |
| Change in WC | $20 | -$8 | $42 | -$40 |
| Other Non-Cash | $7 | $4 | -$183 | $26 |
| Operating Cash Flow | -$12 | -$27 | -$187 | -$208 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$143 | -$135 | -$103 | -$158 |
| Inv. Sales/Matur. | $156 | $103 | $158 | $286 |
| Other Inv. Act. | $0 | $2 | $1,100 | $0 |
| Investing Cash Flow | $12 | -$33 | $1,154 | $124 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$632 | -$11 |
| Stock Issued | $0 | $0 | $0 | $108 |
| Stock Repurch. | -$3 | -$200 | -$132 | -$9 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $1 | $5 | $3 |
| Financing Cash Flow | -$2 | -$199 | -$759 | $92 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | -$259 | $208 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $40 | $299 | $91 | $82 |
| End Cash | $39 | $40 | $299 | $91 |
| Free Cash Flow | -$12 | -$29 | -$188 | -$211 |